Molly Henderson
2020 - Advaxis
In 2020, Molly Henderson earned a total compensation of $413.8K as Executive VP, Chief Financial Officer at Advaxis, a 31% decrease compared to previous year.
Compensation breakdown
| Option Awards | $26,000 |
|---|---|
| Salary | $369,163 |
| Other | $18,593 |
| Total | $413,756 |
Henderson received $369.2K in salary, accounting for 89% of the total pay in 2020.
Henderson also received $26K in option awards and $18.6K in other compensation.
Rankings
In 2020, Molly Henderson's compensation ranked 11,498th out of 13,090 executives tracked by ExecPay. In other words, Henderson earned more than 12.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,498 out of 13,090 | 12th |
Division Manufacturing | 4,920 out of 5,617 | 12th |
Major group Chemicals And Allied Products | 2,027 out of 2,248 | 10th |
Industry group Drugs | 1,768 out of 1,948 | 9th |
Industry Pharmaceutical Preparations | 1,310 out of 1,453 | 10th |
Source: SEC filing on April 21, 2021.
Henderson's colleagues
We found two more compensation records of executives who worked with Molly Henderson at Advaxis in 2020.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
Advaxis CEO Kenneth Berlin's 2020 pay jumps 21% to $1.2M
April 21, 2021